Bio Techne Financials
| TECH Stock | USD 75.38 0.51 0.68% |
Bio |
Understanding current and past Bio Techne Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Bio Techne's financial statements are interrelated, with each one affecting the others. For example, an increase in Bio Techne's assets may result in an increase in income on the income statement.
Bio Techne Stock Summary
Bio Techne competes with Biomarin Pharmaceutical, Vaxcyte, Liquidia Technologies, Legend Biotech, and Alnylam Pharmaceuticals. Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota. Bio-Techne operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3000 people.Specialization | Healthcare, Biotechnology |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US09073M1045 |
| CUSIP | 09073M104 878377100 |
| Location | Minnesota; U.S.A |
| Business Address | 614 McKinley Place |
| Sector | Life Sciences Tools & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.bio-techne.com |
| Phone | 612 379 8854 |
| Currency | USD - US Dollar |
Bio Techne Key Financial Ratios
| Return On Equity | 0.0729 | ||||
| Return On Asset | 0.0555 | ||||
| Target Price | 85.25 | ||||
| Beta | 1.28 | ||||
| Last Dividend Paid | 0.32 |
Bio Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bio Techne's current stock value. Our valuation model uses many indicators to compare Bio Techne value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bio Techne competition to find correlations between indicators driving Bio Techne's intrinsic value. More Info.Bio Techne Corp is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers reporting about 0.76 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Bio Techne Corp is roughly 1.31 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bio Techne's earnings, one of the primary drivers of an investment's value.Bio Techne Corp Systematic Risk
Bio Techne's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Bio Techne volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Bio Techne Corp correlated with the market. If Beta is less than 0 Bio Techne generally moves in the opposite direction as compared to the market. If Bio Techne Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Bio Techne Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Bio Techne is generally in the same direction as the market. If Beta > 1 Bio Techne moves generally in the same direction as, but more than the movement of the benchmark.
About Bio Techne Financials
What exactly are Bio Techne Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Bio Techne's income statement, its balance sheet, and the statement of cash flows. Potential Bio Techne investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Bio Techne investors may use each financial statement separately, they are all related. The changes in Bio Techne's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bio Techne's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Bio Techne November 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Bio Techne help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bio Techne Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bio Techne Corp based on widely used predictive technical indicators. In general, we focus on analyzing Bio Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bio Techne's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.42 | |||
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 14.31 | |||
| Value At Risk | (3.19) | |||
| Potential Upside | 4.15 |
Complementary Tools for Bio Stock analysis
When running Bio Techne's price analysis, check to measure Bio Techne's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Techne is operating at the current time. Most of Bio Techne's value examination focuses on studying past and present price action to predict the probability of Bio Techne's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Techne's price. Additionally, you may evaluate how the addition of Bio Techne to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |